Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2017303578', 'doi': 'https://doi.org/10.1080/10245330701214236', 'title': 'Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma', 'display_name': 'Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma', 'publication_year': 2007, 'publication_date': '2007-06-01', 'ids': {'openalex': 'https://openalex.org/W2017303578', 'doi': 'https://doi.org/10.1080/10245330701214236', 'mag': '2017303578', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17558699'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1080/10245330701214236', 'pdf_url': 'https://www.tandfonline.com/doi/pdf/10.1080/10245330701214236?needAccess=true', 'source': {'id': 'https://openalex.org/S195061619', 'display_name': 'Hematology', 'issn_l': '1024-5332', 'issn': ['1024-5332', '1027-7501', '1607-8454'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320442', 'host_organization_name': 'Maney Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320442'], 'host_organization_lineage_names': ['Maney Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://www.tandfonline.com/doi/pdf/10.1080/10245330701214236?needAccess=true', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5027513506', 'display_name': 'M. Wang', 'orcid': 'https://orcid.org/0009-0000-9433-392X'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'M. Wang', 'raw_affiliation_strings': ['Department of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.'], 'affiliations': [{'raw_affiliation_string': 'Department of Lymphoma/Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070096873', 'display_name': 'Sergio Giralt', 'orcid': 'https://orcid.org/0000-0003-1944-5053'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'S. Giralt', 'raw_affiliation_strings': ['Department of Lymphoma/MyelomaThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Lymphoma/MyelomaThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047673513', 'display_name': 'Kay Delasalle', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'K. Delasalle', 'raw_affiliation_strings': ['Department of Lymphoma/MyelomaThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Lymphoma/MyelomaThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110204025', 'display_name': 'Beverly C. Handy', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'B. Handy', 'raw_affiliation_strings': ['Department of Lymphoma/MyelomaThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Lymphoma/MyelomaThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA', 'institution_ids': ['https://openalex.org/I1343551460']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5007796652', 'display_name': 'Raymond Alexanian', 'orcid': 'https://orcid.org/0000-0002-3030-7404'}, 'institutions': [{'id': 'https://openalex.org/I1343551460', 'display_name': 'The University of Texas MD Anderson Cancer Center', 'ror': 'https://ror.org/04twxam07', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1343551460']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'R. Alexanian', 'raw_affiliation_strings': ['Department of Lymphoma/MyelomaThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Lymphoma/MyelomaThe University of Texas M. D. Anderson Cancer Center, Houston, TX, USA', 'institution_ids': ['https://openalex.org/I1343551460']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2085, 'currency': 'GBP', 'value_usd': 2557, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 10.559, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 115, 'citation_normalized_percentile': {'value': 0.926639, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 97, 'max': 98}, 'biblio': {'volume': '12', 'issue': '3', 'first_page': '235', 'last_page': '239'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 0.9965, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11752', 'display_name': 'Cancer Treatment and Pharmacology', 'score': 0.9922, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/melphalan', 'display_name': 'Melphalan', 'score': 0.7875456}], 'concepts': [{'id': 'https://openalex.org/C2779609412', 'wikidata': 'https://www.wikidata.org/wiki/Q203174', 'display_name': 'Thalidomide', 'level': 3, 'score': 0.94481844}, {'id': 'https://openalex.org/C2777478702', 'wikidata': 'https://www.wikidata.org/wiki/Q419319', 'display_name': 'Bortezomib', 'level': 3, 'score': 0.89439934}, {'id': 'https://openalex.org/C2780401358', 'wikidata': 'https://www.wikidata.org/wiki/Q422252', 'display_name': 'Dexamethasone', 'level': 2, 'score': 0.8873956}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.86718655}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8564534}, {'id': 'https://openalex.org/C2778684742', 'wikidata': 'https://www.wikidata.org/wiki/Q2298283', 'display_name': 'Melphalan', 'level': 3, 'score': 0.7875456}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.57288426}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.4827906}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.38059413}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069286', 'descriptor_name': 'Bortezomib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003907', 'descriptor_name': 'Dexamethasone', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003907', 'descriptor_name': 'Dexamethasone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018380', 'descriptor_name': 'Hematopoietic Stem Cell Transplantation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008558', 'descriptor_name': 'Melphalan', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D008558', 'descriptor_name': 'Melphalan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012074', 'descriptor_name': 'Remission Induction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013792', 'descriptor_name': 'Thalidomide', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D013792', 'descriptor_name': 'Thalidomide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014182', 'descriptor_name': 'Transplantation, Autologous', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1080/10245330701214236', 'pdf_url': 'https://www.tandfonline.com/doi/pdf/10.1080/10245330701214236?needAccess=true', 'source': {'id': 'https://openalex.org/S195061619', 'display_name': 'Hematology', 'issn_l': '1024-5332', 'issn': ['1024-5332', '1027-7501', '1607-8454'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320442', 'host_organization_name': 'Maney Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320442'], 'host_organization_lineage_names': ['Maney Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17558699', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1080/10245330701214236', 'pdf_url': 'https://www.tandfonline.com/doi/pdf/10.1080/10245330701214236?needAccess=true', 'source': {'id': 'https://openalex.org/S195061619', 'display_name': 'Hematology', 'issn_l': '1024-5332', 'issn': ['1024-5332', '1027-7501', '1607-8454'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320442', 'host_organization_name': 'Maney Publishing', 'host_organization_lineage': ['https://openalex.org/P4310320442'], 'host_organization_lineage_names': ['Maney Publishing'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.82, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 27, 'referenced_works': ['https://openalex.org/W1966156828', 'https://openalex.org/W1967381972', 'https://openalex.org/W1978377409', 'https://openalex.org/W1980471295', 'https://openalex.org/W2008182609', 'https://openalex.org/W2025253157', 'https://openalex.org/W2045560618', 'https://openalex.org/W2048141239', 'https://openalex.org/W2078115159', 'https://openalex.org/W2083107653', 'https://openalex.org/W2102591890', 'https://openalex.org/W2108235071', 'https://openalex.org/W2113101033', 'https://openalex.org/W2120161314', 'https://openalex.org/W2120474651', 'https://openalex.org/W2132242107', 'https://openalex.org/W2144531125', 'https://openalex.org/W2166043738', 'https://openalex.org/W2166427186', 'https://openalex.org/W2168929741', 'https://openalex.org/W2170411142', 'https://openalex.org/W2316160054', 'https://openalex.org/W2321655863', 'https://openalex.org/W2333363976', 'https://openalex.org/W2993330168', 'https://openalex.org/W3145716452', 'https://openalex.org/W4231388513'], 'related_works': ['https://openalex.org/W4225390146', 'https://openalex.org/W37180177', 'https://openalex.org/W3127479238', 'https://openalex.org/W2954204180', 'https://openalex.org/W2564869059', 'https://openalex.org/W2124042268', 'https://openalex.org/W2074205062', 'https://openalex.org/W2017303578', 'https://openalex.org/W1964991829', 'https://openalex.org/W1576670771'], 'abstract_inverted_index': {'In': [0, 27], 'a': [1, 65, 93, 128, 168], 'previous': [2], 'trial': [3], 'among': [4], '137': [5], 'previously': [6], 'untreated': [7], 'patients': [8, 48, 106, 110, 135, 158, 176], 'with': [9, 49, 111, 139, 177], 'multiple': [10, 50, 178], 'myeloma,': [11], 'the': [12, 150], 'combination': [13, 164], 'of': [14, 20, 62, 67, 95, 102, 130, 160, 165], 'thalidomide-dexamethasone': [15], 'induced': [16], 'remission': [17, 24, 103, 113, 155], 'in': [18, 25, 64, 104, 153, 156], '66%': [19], 'patients,': [21], 'including': [22, 108], 'complete': [23, 112, 154], '13%.': [26], 'an': [28], 'attempt': [29], 'to': [30, 38, 92], 'induce': [31], 'more': [32, 58], 'frequent': [33], 'remissions,': [34], 'we': [35], 'added': [36], 'bortezomib': [37, 63], 'this': [39], 'program.': [40], 'Between': [41], '7/03': [42], 'and': [43, 125], '3/06,': [44], '38': [45], 'newly': [46, 174], 'diagnosed': [47, 175], 'myeloma': [51, 151], 'received': [52, 136], 'at': [53], 'least': [54], 'one,': [55], 'but': [56, 120], 'no': [57], 'than': [59], '3,': [60], 'courses': [61], 'dose': [66], '1.3': [68], 'mg/m2': [69, 75], 'IV': [70], '×': [71], '4;': [72], 'dexamethasone': [73], '20': [74], 'PO': [76, 89], 'for': [77, 173], '4': [78, 131], 'days': [79, 82], 'beginning': [80], 'on': [81], '1,': [83], '9,': [84], '17;': [85], 'thalidomide': [86], '100': [87], 'mg': [88], 'daily': [90], 'increasing': [91], 'maximum': [94], '200': [96], 'mg.': [97], 'There': [98], 'was': [99, 152, 167], 'rapid': [100], 'onset': [101], '33': [105], '(87%)': [107], '6': [109], '(16%).': [114], 'Most': [115], 'side': [116], 'effects': [117], 'were': [118, 122], 'preventable,': [119], 'otherwise': [121], 'usually': [123], 'mild': [124], 'reversible.': [126], 'After': [127], 'median': [129], 'months,': [132], '25': [133], 'eligible': [134], 'intensive': [137], 'therapy': [138], 'high-dose': [140], 'melphalan': [141], 'supported': [142], 'by': [143], 'autologous': [144], 'blood': [145], 'stem': [146], 'cells,': [147], 'so': [148], 'that': [149], '14': [157], '(37%': [159], 'all': [161], 'patients).': [162], 'The': [163], 'bortezomib-thalidomide-dexamethasone': [166], 'highly': [169], 'effective': [170], 'primary': [171], 'treatment': [172], 'myeloma.': [179]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2017303578', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 1}, {'year': 2017, 'cited_by_count': 3}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 2}, {'year': 2013, 'cited_by_count': 10}, {'year': 2012, 'cited_by_count': 13}], 'updated_date': '2024-12-09T11:30:29.008233', 'created_date': '2016-06-24'}